Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Clinical Case Reports|December 3, 2019
Salvage therapy with azacitidine for pediatric acute myeloid leukemia with t(16;21)(p11;q22)/<i>FUS-ERG</i> and early relapse after allogeneic blood stem cell transplantation: A case reportDai Keino, Takashi Mori, Mizuho Morimoto, et al.Kyobu Geka. the Japanese Journal of Thoracic Surgery|May 12, 2021
[Endoventricular Stepwise Plication for Left Ventricular Aneurysm]Noriyuki Tokunaga, Tatsuya Watanabe, Kensuke Kondo, et al.Blood Pressure Monitoring|January 1, 2016
Comparison of telmisartan/amlodipine and telmisartan/hydrochlorothiazide in the treatment of Japanese patients with uncontrolled hypertension: the TAT-Kobe studyKensuke Kondo, Ryuji Toh, Tatsuro Ishida, et al.Journal of Plant Physiology|November 5, 2003
Role of 5-aminolevulinic acid (ALA) on active oxygen-scavenging system in NaCl-treated spinach (Spinacia oleracea)Eiji Nishihara, Kensuke Kondo, Mohammad Masud Parvez, et al.JACC. Case Reports|August 1, 2025
Calculation of the Optimal Angiographic View Using Intravascular Ultrasound by the Tip Detection MethodYohei Fukata, Ryohei Yoshikawa, Atsunori Okamura, et al.BMC Cancer|June 1, 2022
Efficacy of osimertinib in epidermal growth factor receptor-mutated non-small-cell lung cancer patients with pleural effusionHiroshi Nokihara, Hirokazu Ogino, Atsushi Mitsuhashi, et al.Thoracic Cancer|December 3, 2021
A case of pulmonary pleomorphic carcinoma with preexisting interstitial pneumonia successfully treated with pembrolizumabMasahiro Sako, Hiroshi Nokihara, Kensuke Kondo, et al.Thoracic Cancer|December 13, 2023
An increased relative eosinophil count as a predictive dynamic biomarker in non-small cell lung cancer patients treated with immune checkpoint inhibitorsEiji Takeuchi, Hirokazu Ogino, Kensuke Kondo, et al.Thoracic Cancer|September 5, 2023
Pretreatment eosinophil counts as a predictive biomarker in non-small cell lung cancer patients treated with immune checkpoint inhibitorsEiji Takeuchi, Kensuke Kondo, Yoshio Okano, et al.Journal of Cancer Research and Clinical Oncology|July 24, 2022
Early mortality factors in immune checkpoint inhibitor monotherapy for advanced or metastatic non-small cell lung cancerEiji Takeuchi, Kensuke Kondo, Yoshio Okano, et al.Pageof 2